Dr. McMahon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Harrison Ave
# Moakley
Boston, MA 02118Phone+1 617-638-6428Fax+1 617-638-5756
Education & Training
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1966 - 1969
- Steward Carney HospitalResidency, Internal Medicine, 1965 - 1966
- Steward Carney HospitalInternship, Transitional Year, 1964 - 1965
Certifications & Licensure
- MA State Medical License 1973 - 2025
Clinical Trials
- Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence Start of enrollment: 2005 Aug 01
- Effectiveness of Arginine as a Treatment for Sickle Cell Anemia Start of enrollment: 2004 Jun 01
- A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 2 citationsRecognition of hemophagocytic lymphohistiocytosis in sickle cell vaso-occlusive crises is a potentially lifesaving diagnosisOrly Leiva, Lillian McMahon, J. Mark Sloan, John C. Lee, Adam Lerner
Haematologica. 2019-04-01 - 29 citationsSelf-Reported Transition Readiness among Young Adults with Sickle Cell DiseaseAmy Sobota, Adeola Akinlonu, Maria Champigny, Megan Eldridge, Lillian McMahon
Journal of Pediatric Hematology/oncology. 2014-07-01 - 53 citationsA double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTheodore Wun, Denis Soulières, Andrew L. Frelinger, Lakshmanan Krishnamurti, Enrico M. Novelli
Journal of Hematology & Oncology. 2013-02-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: